Palico, the private equity fund marketplace

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

About OrbiMed Royalty Opportunities Fund

OrbiMed Royalty Opportunities Fund is a private equity general partner firm headquartered in New York, NY, United States and has other offices in China, India, Israel and United States.

Invest in OrbiMed Royalty Opportunities Fund funds

Hundreds of fund managers are currently fundraising on Palico.

Already a member? Log in.

Funds managed by OrbiMed Royalty Opportunities Fund

Closed and liquidated funds managed by OrbiMed Royalty Opportunities Fund:
Fund name Size Vintage Status
OrbiMed Royalty Opportunities Fund II USD 924m 2015 Closed
Royalty opportunities fund USD 600m 2011 Closed

News about OrbiMed Royalty Opportunities Fund

Sep 03, 2015

OrbiMed-backed Unilife, which makes injections and insulin patch pumps, is reviewing strategic alternatives, including a sale.

Mar 02, 2015

Healthcare-focused OrbiMed issued $60m in debt to Unilife, a US-based company that designs and manufactures injectable drug delivery systems

Nov 22, 2013

Iroko Pharmaceuticals, a global specialty pharmaceutical company focused on analgesia, has secured a $75m debt facility from OrbiMed.

Read more news about OrbiMed Royalty Opportunities Fund

Other investment strategies pursued by the same firm

This firm also pursues other investment strategies:

OrbiMed Asia logo

OrbiMed Asia

China
Invest in Private Equity

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

Already a member? Log in.